Whiteoak Capital Pharma And Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 30-09-2026
NAV ₹16.5(R) -1.81% ₹17.28(D) -1.81%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 22.05% -% -% -% -%
Direct 24.16% -% -% -% -%
Benchmark
SIP (XIRR) Regular 27.5% -% -% -% -%
Direct 29.72% -% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Fund AUM As on: 30/12/2025 486 Cr
Top Pharma Fund
Fund Name Rank Rating
SBI Healthcare Opportunities Fund -
UTI Healthcare Fund -
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
DSP Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -
Mirae Asset Healthcare Fund -
Nippon India Pharma Fund -
Tata India Pharma & Healthcare Fund -

NAV Date: 30-09-2026

Scheme Name NAV Rupee Change Percent Change
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth 16.5
-0.3000
-1.8100%
WhiteOak Capital Pharma and Heathcare Fund Direct Plan Growth 17.28
-0.3200
-1.8100%

Review Date: 30-09-2026

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -3.21 -2.75
-3.67
-5.29 | -1.85 5 | 17 Very Good
3M Return % 3.45 4.65
2.82
-1.56 | 5.47 7 | 17 Good
6M Return % 23.25 19.34
21.01
14.32 | 27.55 7 | 17 Good
1Y Return % 22.05 23.98
17.84
7.91 | 27.76 4 | 16 Very Good
1Y SIP Return % 27.50
22.87
10.43 | 35.54 6 | 16 Good
Return data last Updated On : Sept. 30, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -3.06 -2.75 -3.57 -5.18 | -1.73 5 | 17 Very Good
3M Return % 3.91 4.65 3.16 -1.37 | 5.93 6 | 17 Good
6M Return % 24.33 19.34 21.84 14.81 | 28.55 7 | 17 Good
1Y Return % 24.16 23.98 19.45 9.46 | 29.80 4 | 16 Very Good
1Y SIP Return % 29.72 24.48 11.42 | 37.66 6 | 15 Good
Return data last Updated On : Sept. 30, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Whiteoak Capital Pharma And Healthcare Fund NAV Regular Growth Whiteoak Capital Pharma And Healthcare Fund NAV Direct Growth
30-09-2026 16.503 17.282
29-09-2026 16.808 17.601
28-09-2026 16.79 17.582
25-09-2026 17.015 17.815
24-09-2026 17.035 17.835
23-09-2026 17.165 17.971
22-09-2026 16.994 17.791
21-09-2026 17.105 17.906
18-09-2026 17.001 17.79
17-09-2026 16.831 17.611
16-09-2026 16.618 17.388
15-09-2026 16.688 17.46
11-09-2026 16.974 17.756
10-09-2026 17.052 17.837
09-09-2026 17.062 17.846
08-09-2026 17.063 17.847
07-09-2026 16.899 17.675
04-09-2026 16.781 17.549
03-09-2026 16.891 17.663
02-09-2026 16.876 17.646
01-09-2026 16.896 17.667
31-08-2026 17.05 17.827

Fund Launch Date: 06/Feb/2024
Fund Category: Pharma Fund
Investment Objective: To provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Description: An open ended equity scheme investing in Pharma and Healthcare sector
Fund Benchmark: BSE Healthcare Total Return Index
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.